![James Neal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Neal
Director/Board Member at
PROCESSA PHARMACEUTICALS, INC.
Net worth: 2 506 $ as of 2025-05-30
Profile
Mr. James R. Neal is a Chairman at Palisade Bio, Inc., a Chief Executive Officer & Director at XOMA Corp. and a Chief Executive Officer at XOMA (US) LLC. He is on the Board of Directors at Leading Biosciences, Inc. and XOMA Corp. Mr. Neal was previously employed as a President & Chief Executive Officer by Entelos, Inc., a Chief Executive Officer & Director by Iconix Biosciences, Inc., an EVP-Sales, Marketing & Business Development by Incyte Genomics Inc. /Micoarray Operations/, a General Manager by The Solaris Group, a Partner by Eli Lilly & Co. Ltd., a Partner by GlaxoSmithKline Pharmaceuticals SA (Belgium), a Principal by Monsanto Co., and a Chief Executive Officer by US Food & Drug Administration. He received his undergraduate degree from the University of Manitoba, a graduate degree from the University of Manitoba and an MBA from Washington University in St. Louis.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-28 | 818 ( 0.03% ) | 2 094 $ | 2026-05-30 | |
| 2025-12-30 | 41,144,000 ( 0.08% ) | 411 $ | 2025-05-30 |
James Neal active positions
| Companies | Position | Start |
|---|---|---|
| MONTEREY INNOVATION ACQUISITION CORP. | Director/Board Member | 2023-03-08 |
| PROCESSA PHARMACEUTICALS, INC. | Director/Board Member | 2022-07-15 |
| AKARI THERAPEUTICS, PLC | Director/Board Member | 2024-11-12 |
XOMA (US) LLC
 XOMA (US) LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical preparations | Chief Executive Officer | - |
Former positions of James Neal
| Companies | Position | End |
|---|---|---|
| PEAK BIO, INC. | Director/Board Member | 2024-11-13 |
| PALISADE BIO, INC. | Chairman | 2024-02-08 |
| XOMA ROYALTY CORPORATION | Chief Executive Officer | 2022-12-31 |
| PALISADE BIO, INC. | Chairman | 2021-04-28 |
Entelos, Inc.
 Entelos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical trial partner that supports drug research and development teams | Chief Executive Officer | 2009-09-10 |
Training of James Neal
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
61
1st degree connections
19
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 19 |
|---|---|
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Monsanto Co.
 Monsanto Co. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company controlling insects and weeds & manufactures seeds and genomics | Commercial Services |
Iconix Biosciences, Inc.
 Iconix Biosciences, Inc. BiotechnologyHealth Technology Provides toxicogenomics products and services | Health Technology |
Entelos, Inc.
Entelos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical trial partner that supports drug research and development teams | Commercial Services |
The Solaris Group
 The Solaris Group Chemicals: AgriculturalProcess Industries Manufactures plant food | Process Industries |
Incyte Genomics Inc. /Micoarray Operations/
 Incyte Genomics Inc. /Micoarray Operations/ Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical drug discovery and development services | Commercial Services |
University of Manitoba
 University of Manitoba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eli Lilly & Co. Ltd.
 Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical health care solutions | Health Technology |
Seneca Biopharma, Inc.
 Seneca Biopharma, Inc. BiotechnologyHealth Technology Manufactures biotherapeutic products | Health Technology |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
XOMA (US) LLC
XOMA (US) LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical preparations | Health Technology |
GlaxoSmithKline Pharmaceuticals SA (Belgium)
 GlaxoSmithKline Pharmaceuticals SA (Belgium) Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals and vaccines | Health Technology |
Akari Therapeutics Plc
 Akari Therapeutics Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapies for autoimmune and inflammatory diseases | Health Technology |
Processa Pharmaceuticals, Inc.
 Processa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
Leading Biosciences, Inc.
 Leading Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic approaches for obesity and diabetes | Commercial Services |
Palisade Bio, Inc.
 Palisade Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late stage biopharmaceutical company which develops therapies for acute and chronic gastrointestinal disorders | Health Technology |
Monterey Innovation Acquisition Corp.
 Monterey Innovation Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Peak Bio, Inc.
 Peak Bio, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics to treat oncology and inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- James Neal
